Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Lowered to $40 at BofA Securities

April 30, 2026 4:35 AM
BofA Securities analyst Jason Gerberry lowered the price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change